Cargando…
IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis
Diffuse infiltration is the main reason for therapeutic resistance and recurrence in glioblastoma (GBM). However, potential targeted therapies for GBM stem-like cell (GSC) which is responsible for GBM invasion are limited. Herein, we report Insulin-like Growth Factor-Binding Protein 5 (IGFBP5) is a...
Autores principales: | Lin, Weiwei, Niu, Rui, Park, Seong-Min, Zou, Yan, Kim, Sung Soo, Xia, Xue, Xing, Songge, Yang, Qingshan, Sun, Xinhong, Yuan, Zheng, Zhou, Shuchang, Zhang, Dongya, Kwon, Hyung Joon, Park, Saewhan, Il Kim, Chan, Koo, Harim, Liu, Yang, Wu, Haigang, Zheng, Meng, Yoo, Heon, Shi, Bingyang, Park, Jong Bae, Yin, Jinlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033905/ https://www.ncbi.nlm.nih.gov/pubmed/36949068 http://dx.doi.org/10.1038/s41467-023-37306-1 |
Ejemplares similares
-
ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021) -
ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
por: Rebagay, Guilly, et al.
Publicado: (2012) -
New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome
por: Raivola, Juuli, et al.
Publicado: (2022) -
Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019) -
Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
por: Bainbridge, Travis W., et al.
Publicado: (2014)